%PDF-1.4
%
46 0 obj
<>
endobj
43 0 obj
<>
endobj
106 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-02-05T15:59:36Z
2024-03-28T17:34:13-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T17:34:13-07:00
application/pdf
Heather
2003-321.march
uuid:0e5cf222-1dd2-11b2-0a00-cb08276d7200
uuid:0e5cf225-1dd2-11b2-0a00-b80000000000
endstream
endobj
32 0 obj
<>
endobj
33 0 obj
<>
endobj
47 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 20 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 22 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 24 0 R/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 26 0 R/Type/Page>>
endobj
120 0 obj
[124 0 R]
endobj
121 0 obj
<>stream
q
0 0 612 792 re
W n
BT
0.8 g
/T1_0 18 Tf
0.6114 0.7912 -0.7912 0.6114 35.383 35.2215 Tm
(Personal, non-commercial use only. The Journal of Rheumatology. Copyrigh\
t \251 2004. All rights reserved.)Tj
ET
Q
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.10291 Tw 10 0 0 10 54 713.1616 Tm
[(impact on the child and family)64.8 (, especially among children)]TJ
0.3028 Tw 0 -1.2 TD
(with frequent nocturnal attacks. Some children need to)Tj
0.0687 Tw T*
(chronically use medications, especially acetaminophen and)Tj
0.0152 Tw T*
(nonsteroidal antiinflammatory drugs \(NSAID\). In our study)Tj
0.06889 Tw T*
(52% of the children used medications to relieve their pain.)Tj
-0.0078 Tw T*
(Similar to FM, our findings of lower pain thresholds in chil-)Tj
-0.02521 Tw T*
[(dren with GP)-188 (may have therapeutic implications. Behavioral)]TJ
0.0266 Tw T*
[(intervention to decrease pain sensitivity)64.8 (, as well as physical)]TJ
0.1167 Tw T*
(activity programs to increase fitness may decrease painful)Tj
-0.0282 Tw T*
[(episodes. )17.8 (The physical activity of most children in this study)]TJ
0.0706 Tw T*
[(was reported by their parents to be normal for age. )17.6 (W)79.9 (e)0.1 ( are)]TJ
0.2139 Tw T*
(not aware of any studies that have found an association)Tj
0.02499 Tw T*
[(between physical fitness and GP)-238.3 (attacks.)]TJ
0.01379 Tw 1.2 -1.2 Td
(Unlike other studies of pain syndromes, including FM in)Tj
-0.034 Tw -1.2 -1.2 Td
[(adolescents, we did not find dif)17.7 (ferences in the pain threshold)]TJ
-0.00681 Tw T*
[(between boys and girls in both children with GP)-206.5 (and control)]TJ
0 Tw T*
(subjects)Tj
0 Tc 6.5 0 0 6.5 86.2119 524.4616 Tm
(12)Tj
-0.00011 Tc 0.32359 Tw 10 0 0 10 92.7118 521.1616 Tm
[(. )17.8 (The age of children with GP)-536.8 (is lower than)]TJ
0.03329 Tw -3.8712 -1.2 Td
[(reported studies of FM. It is possible that the gender dif)17.7 (fer-)]TJ
0.097 Tw T*
(ences in pain thresholds are apparent only after late child-)Tj
0.1304 Tw T*
(hood. Even in the control group many tender points were)Tj
0 Tc 0 Tw T*
(found.)Tj
-0.00011 Tc 0.1347 Tw 1.2 -1.2 Td
(Although FM is associated with hypermobility and the)Tj
-0.0338 Tw -1.2 -1.2 Td
(clinical impression of many physicians is that many children)Tj
0.07829 Tw T*
[(with GP)-291.6 (are hypermobile, we did not assess hypermobility)]TJ
-0.00121 Tw T*
[(in this study)64.8 (, since many of the patients and control subjects)]TJ
0.1216 Tw T*
(were of ages in which criteria for hypermobility were not)Tj
0.02499 Tw T*
(formally established)Tj
0 Tc 0 Tw 6.5 0 0 6.5 135.6074 404.4616 Tm
(16,17)Tj
10 0 0 10 150.2323 401.1616 Tm
(.)Tj
-0.00011 Tc 0.05991 Tw -8.4232 -1.2 Td
[(In summary we found that children with GP)-273.2 (have lower)]TJ
0.1718 Tw -1.2 -1.2 Td
[(pain thresholds than control children. )17.7 (Therefore, GP)-385.1 (may)]TJ
-0.00571 Tw T*
(represent a type of noninflammatory pain syndrome in early)Tj
0.05209 Tw T*
(childhood. Longterm outcome studies should be performed)Tj
0.1124 Tw T*
(to investigate whether these children are prone to develop)Tj
0.01089 Tw T*
(other noninflammatory pain syndromes later in adolescence)Tj
0.02499 Tw T*
(or adulthood.)Tj
/T1_2 1 Tf
0 Tw 0 -2.2 TD
(ACKNOWLEDGMENTS)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 54 285.1616 Tm
[(W)79.9 (e thank )36.8 (Y)99.8 (asmin Schwartz for her assistance in statistical analysis.)]TJ
/T1_2 1 Tf
0 Tw 10 0 0 10 318 713.1616 Tm
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 325.6 703.1616 Tm
[(1.)-550.1 (Passo MH. )54.8 (Aches and limb pain. Pediatr Clin North )54.8 (Am)]TJ
0 Tc 0 Tw 1.3 -1.25 Td
(1982;29:209-19.)Tj
-0.00011 Tc 0.02499 Tw -1.3 -1.25 Td
[(2.)-550.1 (Bowyer SL, Hollister JR. Limb pain in childhood. Pediatr Clin)]TJ
0 Tc -0.02991 Tw 1.3 -1.25 Td
[(North Am )-54.9 (1984;34:1053-81.)]TJ
-0.00011 Tc 0.02499 Tw -1.3 -1.25 Td
[(3.)-550.1 (Naish JM, )54.8 (Apley J. Growing pains: a clinical study of non-arthritis)]TJ
1.3 -1.25 Td
[(limb pains in children. )54.8 (Arch Dis Child 1951;26:134-40.)]TJ
-1.3 -1.25 Td
[(4.)-550.1 (Brenning R. Growing pain. )54.8 (Acta Soc Med Ups 1960;65:185-201.)]TJ
0 -1.25 TD
[(5.)-550.1 (Oster J, Nielson )54.8 (A. Growing pain: a clinical investigation of a)]TJ
1.3 -1.25 Td
[(school population. )54.8 (Acta Paediatr Scand 1972;61:329-34.)]TJ
-1.3 -1.25 Td
[(6.)-550.1 (Calabro JJ, )17.7 (W)79.9 (achtel )54.8 (AE, Holgerson )17.7 (WB, Repice MM. Growing)]TJ
1.3 -1.25 Td
(pains: fact or fiction? Postgrad Med 1976;59:66-72.)Tj
-1.3 -1.25 Td
[(7.)-550.1 (W)79.9 (einer SR. Growing pains. )54.8 (Am Fam Physician 1983;27:189-91.)]TJ
T*
[(8.)-550.1 (Peterson H. Growing pains. Pediatr Clin North )54.8 (Am )]TJ
0 Tc 0 Tw 1.3 -1.25 Td
(1986;33:1365-72.)Tj
-0.00011 Tc 0.02499 Tw -1.3 -1.25 Td
[(9.)-550.1 (Leung )54.8 (AKS, Robson )17.7 (WLM. Growing pains. Can Fam Physician)]TJ
0 Tc 0 Tw 1.3 -1.25 Td
(1991;37:1463-7.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(10.)-550.1 (Manners P)110.8 (.)-0.1 ( )54.8 (Are growing pains a myth? )54.8 (Aust Fam Physician)]TJ
0 Tc 0 Tw 1.8 -1.25 Td
(1999;28:124-7.)Tj
-0.00011 Tc 0.02499 Tw -1.7631 -1.25 Td
[(1)36.8 (1)-0.1 (.)-550.1 (Atar D, Lehman )17.7 (WB, Grant )54.8 (AD. Growing pains. Orthop Rev)]TJ
0 Tc 0 Tw 1.7631 -1.25 Td
(1991;20:133-6.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(12.)-550.1 (Buskila D, Press J, Gedalia )54.8 (A, et al. )54.8 (Assessment of nonarticular)]TJ
1.8 -1.25 Td
(tenderness and prevalence of fibromyalgia in children. J Rheumatol)Tj
0 Tc 0 Tw T*
(1993;20:368-70.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(13.)-550.1 (Y)110.8 (unus MB, Masi )54.8 (A)110.8 (T)74 (. Juvenile primary fibromyalgia syndrome. )54.8 (A)]TJ
1.8 -1.25 Td
(clinical study of thirty-three patients and matched normal controls.)Tj
T*
(Arthritis Rheum 1985;28:138-45.)Tj
-1.8 -1.25 Td
[(14.)-550.1 (Buskila D, Neuman L, Hershman E, Gedalia )54.8 (A, Press J, Sukenik S.)]TJ
1.8 -1.25 Td
[(Fibromyalgia syndrome in children: an outcome study)64.8 (. J Rheumatol)]TJ
0 Tc 0 Tw T*
(1995;22:525-8.)Tj
-0.00011 Tc 0.02499 Tw -1.8 -1.25 Td
[(15.)-550.1 (Siegel DM, Janeway D, Baum J. Fibromyalgia syndrome in children)]TJ
1.8 -1.25 Td
(and adolescents: clinical features at presentation and status at)Tj
T*
(follow-up. Pediatrics 1998;101:377-82.)Tj
-1.8 -1.25 Td
[(16.)-550.1 (Gedalia )54.8 (A, Press J, Klein M, Buskila D. Joint hypermobility and)]TJ
1.8 -1.25 Td
[(fibromyalgia in schoolchildren. )54.8 (Ann Rheum Dis 1993;52:494-6.)]TJ
-1.8 -1.25 Td
[(17.)-550.1 (van der Giessen LJ, Liekens D, Rutgers KJ, Hartman )54.8 (A, Mulder PG,)]TJ
1.8 -1.25 Td
[(Oranje )54.8 (AP)110.8 (. )17.7 (V)110.8 (alidation of Brighton score and prevalence of )]TJ
T*
(connective tissue signs in 773 Dutch children. J Rheumatol)Tj
0 Tc 0 Tw T*
(2001;28:2726-30.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_3 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 54.5 35.9844 Tm
[(Hashkes, et al: Pain thr)36.8 (eshold in childr)36.8 (en)]TJ
0 Tc 0 Tw 61.4375 -0.0313 Td
(613)Tj
ET
0 0 0 0 k
/GS0 gs
109.22 59.08 396.48 -10.83 re
f*
0.5 w
109.22 59.08 396.48 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_4 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2004. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_5 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
26 0 obj
<>stream
8;Z\7>7L`Y#itt$SEi#2J65\=Yt<]k8,KOs1BXp6E:)@T)0O1`KOVX.l^7,gliCQ[
p.$ZW)u;,+:O#N(gNk0+RZ!575#Y(/1ADnC.caW,T:s<1O@,agp6`h+LI+tW%^nnZ
@X`\+WHkbe;Z!$=QqCU)`!SNV^qW9INi,TJURNR(IAS8In,ntH)g[pDfU=eC1M9X+
2jjLh#9GZ^Bjk4i.GGcBK!"s>""dKi=Q0r>&bI$^+k>/C!/t)l4,^a+;-.[sis:eVJL&R%#_f(iU%_d\TQA7!1;.8OC_&oR%HdpK?F1k59:.
p$+N#Zlb3JXg@MYjdSr1oiCTcj&qCN\e?(Fr@K&;WT/Go7qtL#88k9<@n-)?2n<5P
Z<68c3A'3@aeppI?;k9ffu!YJB=^eC*qP8&p1eB0/)&beS]NYL(G&NH/,fn!TQV]j
J#6W2ALDhgV"8+"6b;goe8*[=?+Y:Ig9h+MDhl/oE?WE>-*,?e56.\oe`#JB5lJ=.
"ot4=EX2~>
endstream
endobj
30 0 obj
[/Indexed/DeviceRGB 255 29 0 R]
endobj
29 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
88 0 obj
<>
endobj
54 0 obj
<>
endobj
61 0 obj
<>
endobj
50 0 obj
<>
endobj
97 0 obj
<>
endobj
111 0 obj
<>
endobj
49 0 obj
<>
endobj
81 0 obj
<>stream
HTyTSg𒇆D3VHVQqE@vDYa_ @DYh[n7flgo[A#
2P,I<$&IQra@ x[+H24}۱@$D Ҩ8JzD 9,%J$s *1fD*dh(F% e־c1h fib=pl9cmİm$36Lj10ی`W&ӌF
3b=qla9I[jfmV`v{іE׳ysWR
b ՂY[d`SؘdLE;
8FS)WȊymx\ܒYWʋ6kdtYzfF!Y82R(y?$399%1(
nA"Q($K9x}.;Ra dԼޫ/;eLtzDw3tZ\2Ė1.?絙߸Ţ29_"SMk}
G$T?bk)Mr]GwTW_#ʈ+)Sϊ(VW9qxA/唊
y`?ՌMLNbdR*/(Vw7jj$j?;Hx Ѡ
h'{.t@(3ji;~h4Eʍ#+H+, #떻Y2%)EVyAf<2:.`ym3!s^ztsOrqy^5):|Qy~3_p'T}I`6OL io.xSH)xNp;hA0Z*ϷrC_%ת_yT;L>g`>mі*b)CդVdDIx:Mu
F>rIݑԮ,Jh 9mV
7tUk:oMʼn͞uw$v1|p)6^7o\ԽTƜ=Arw55?zR}9vfJ֡|0r3=07U`ZFB<